Streetbeat News

Partnerships

DDD

3D Systems has partnered with Klarity to expand access to patient-matched radiotherapy innovations. Klarity now offers Klarity Prints™ Powered by 3D Systems, and has added VSP® Bolus to its range of radiotherapy solutions. This partnership allows radiotherapy clinics in the United States and Canada to use 3D printing technology without investing in expensive software.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:32 pm

AAPL

ARM

QCOM

SSNLF

TSM

Qualcomm is preparing to launch its Snapdragon 8 Gen 3, which will be manufactured under TSMC's 4nm and 3nm processes. The new chip will use Arm Holdings' latest CPU cores. The Snapdragon 8 Gen 3 is set to rival Apple's 3nm A17 Pro Bionic chipset, which is currently the only commercially available 3nm chipset. TSMC has also won orders for Nvidia's next-generation AI processor B100, which requires the 3nm process fabrication.

Portfolio Pulse from Anusuya Lahiri

September 27, 2023 | 12:28 pm

DNA

PFE

Ginkgo Bioworks has announced a collaboration with Pfizer to discover RNA-based drug candidates, leading to a rise in Ginkgo's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:25 pm

DIS

NFLX

PARA

WBD

A tentative labor agreement between Hollywood studios and the Writers Guild of America (WGA) will likely allow studios to continue training AI models using writers' works. This is a relief for Warner Bros. Discovery, Inc (WBD), Paramount Global (PARA), Netflix, Inc (NFLX) and Walt Disney Co (DIS). However, writers will receive credit and compensation for their contributions, even when AI tools are used. This follows a nearly five-month strike and ongoing negotiations with the Alliance of Motion Picture and Television Producers (AMPTP).

Portfolio Pulse from Anusuya Lahiri

September 27, 2023 | 12:25 pm

NET

Cloudflare has announced a partnership with Meta to make the Llama 2 open source large language model available to developers building AI applications on Cloudflare's developer platform, Workers. This has led to a rise in Cloudflare's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:24 pm

Visa has expanded its Installments Program to include Air Transat and London Drugs. This move is expected to provide customers with more flexibility in payments and could potentially increase Visa's transaction volume.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:09 pm

GENE

Genetic Technologies has announced a partnership with the Gold Coast Private Hospital (GCPH) to establish a precision medicine clinic at the hospital. The partnership will be initiated with a 50-patient pilot study to establish workflow and patient reporting. The pilot study will utilize Genetype multi-risk test combined with pharmacogenomics tests, providing a comprehensive wellness profile for GCPH patients.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:08 pm

MMTOF

MTSUY

Mitsubishi Motors has decided to cease automobile production in China due to rising EV popularity and strong local brands. The company has started final withdrawal talks with China's Guangzhou Automobile Group (GAC), with which Mitsubishi has a joint venture. GAC Mitsubishi Motors owns a manufacturing plant in Hunan province, which ceased production in March. GAC plans to convert the Hunan plant for EV manufacturing. Mitsubishi Motors and Mitsubishi Corp. are pulling their investments.

Portfolio Pulse from Akanksha Bakshi

September 27, 2023 | 12:06 pm

GFS

MCHP

GlobalFoundries (NASDAQ:GFS) and Microchip Technology (NASDAQ:MCHP) have announced the immediate release to production of the SST ESF3 third-generation embedded SuperFlash technology NVM solution in the GF 28SLPe foundry process. The implementation delivers a low-cost 28-nm HKMG ESF3 solution with only 10 masks added, including true 5V IO CMOS devices. The use cases for embedded flash are increasing with the drive for more intelligence at the edge.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:04 pm

TWST

Twist Bioscience and IMIDomics have announced a collaboration to discover antibodies for applications in immune-mediated inflammatory diseases. The partnership will leverage Twist Bioscience's proprietary antibody discovery platform.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 12:04 pm